Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2022 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Role of mesenchymal stromal cells derivatives in diabetic foot ulcers: a controlled randomized phase 1/2 clinical trial.
Cytotherapy. 2022 Oct;24(10):1035-1048. doi: 10.1016/j.jcyt.2022.04.002. Epub 2022 Jul 2.
Cytotherapy. 2022.
PMID: 36084965
Clinical Trial.
A novel therapeutic management for diabetes patients with chronic limb-threatening ischemia: comparison of autologous bone marrow mononuclear cells versus allogenic Wharton jelly-derived mesenchymal stem cells.
Arango-Rodríguez ML, Mateus LC, Sossa CL, Becerra-Bayona SM, Solarte-David VA, Ochoa Vera ME, Viviescas LTG, Berrio AMV, Serrano SE, Vargas O, Isla AC, Benitez A, Rangel G.
Arango-Rodríguez ML, et al. Among authors: mateus lc.
Stem Cell Res Ther. 2023 Aug 25;14(1):221. doi: 10.1186/s13287-023-03427-z.
Stem Cell Res Ther. 2023.
PMID: 37626416
Free PMC article.
Clinical Trial.
Item in Clipboard
Mesenchymal stem cells derivatives as a novel and potential therapeutic approach to treat diabetic foot ulcers.
Becerra-Bayona SM, Solarte-David VA, Sossa CL, Mateus LC, Villamil M, Pereira J, Arango-Rodríguez ML.
Becerra-Bayona SM, et al. Among authors: mateus lc.
Endocrinol Diabetes Metab Case Rep. 2020 Jul 5;2020:19-0164. doi: 10.1530/EDM-19-0164. Online ahead of print.
Endocrinol Diabetes Metab Case Rep. 2020.
PMID: 32698128
Free PMC article.
Item in Clipboard
Cite
Cite